GlassScriptPhysician profile
Laura E Langford
NPI 1851821615
$2,015.41
in general payments reported to CMS, 2019-2025
17 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.67 · 2020: $91.94 · 2021: $195 · 2022: $111 · 2023: $594 · 2024: $530 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $533.04 | 2019-2025 | Clareon, Clareon Panoptix Pro, Rocklatan |
| Abbvie INC. | $513.87 | 2023-2025 | |
| Oyster Point Pharma, INC. | $219.73 | 2023-2024 | Tyrvaya, Ryzumvi |
| Dompe US, INC. | $218.70 | 2022-2024 | Oxervate |
| Sun Pharmaceutical Industries INC. | $146.13 | 2020-2024 | Cequa |
| Ani Pharmaceuticals, INC. | $42.19 | 2025 | Purified Cortrophin Gel |
| Bausch & Lomb Americas INC. | $42.19 | 2022-2024 | Vyzulta |
| Tarsus Pharmaceuticals, INC. | $41.99 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $39.29 | 2022-2025 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Shire North American Group INC | $35.92 | 2019 | |
| Genentech USA, INC. | $34.20 | 2023 | Vabysmo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.07 | 2020 | |
| Lkc Technologies, INC. | $28.93 | 2025 | |
| Quidel Corporation | $18.18 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17.36 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Langford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.